Sprint Interval Training Improves BDNF-Induced Benefits in Brain Health

This 2024 review examined the molecular mechanisms by which sprint interval training (SIT) elevates brain-derived neurotrophic factor (BDNF) — often described as the brain's "growth hormone." BDNF is a protein critical for neuron growth, synapse formation, learning, memory consolidation, and protection against neurodegenerative diseases including Alzheimer's. The paper analyzed how exercise at 80–100% VO2max activates the specific biological pathways responsible for BDNF production and release.

The review identified two primary signaling pathways through which sprint-level exercise drives BDNF expression: the PKA/Akt/CREB pathway and the MAPK/ERK/CREB pathway. Both pathways converge on CREB — a transcription factor that directly activates the BDNF gene. Importantly, the magnitude of BDNF response was intensity-dependent: low and moderate-intensity exercise activated these pathways modestly, while sprint-level effort produced substantially greater BDNF increases. The paper also found that SIT improved BDNF transport across the blood-brain barrier, meaning more of the circulating BDNF reached brain tissue.

For men over 50, BDNF is one of the most compelling reasons to sprint. BDNF levels decline with age and are associated with cognitive decline, depression, and increased dementia risk. This review demonstrates that the specific intensity of sprinting — not just general exercise — is required to reliably activate the molecular machinery that produces BDNF. A walk or a jog will not deliver the same neurological stimulus. The evidence suggests that sprint intervals may be one of the most powerful non-pharmacological tools for protecting brain health as we age.